Patents by Inventor Joseph Kuranda

Joseph Kuranda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220323443
    Abstract: The present disclosure relates to the treatment of cancer using a combination therapy comprising Compound 1 and/or tautomers thereof or a pharmaceutically acceptable salt or hydrate thereof, and a second therapy.
    Type: Application
    Filed: July 17, 2020
    Publication date: October 13, 2022
    Inventors: Akihiro Ohashi, Kenichi Iwai, Tadahiro Nambu, Jie Yu, Kurt Eng, Michael Joseph Kuranda, Kazuho Nishimura, Cong Li
  • Publication number: 20080021283
    Abstract: A apparatus and method for retracting tissue of a patient during the performance of an orthopaedic surgical procedure includes creating an incision in a tissue of the patient in the presence of a magnetic field. The magnetic field is generated by a computer assisted orthopaedic surgery system. The tissue surrounding the incision is retracted with a nonmagnetic retractor. The method may also include altering the shape of the nonmagnetic retractor.
    Type: Application
    Filed: July 24, 2006
    Publication date: January 24, 2008
    Inventor: Joseph Kuranda
  • Patent number: 6046000
    Abstract: The invention involves a method of identifying nucleic acid sequences encoding signal peptide-containing proteins. The method features chimeric constructs containing a KRE9 gene that lacks a signal sequence. Yeast containing chimeric KRE9 plasmid constructs that encode signal sequences are selected based on their ability to grow on media in which sucrose is the sole carbon source.
    Type: Grant
    Filed: November 7, 1997
    Date of Patent: April 4, 2000
    Assignee: Millennium BioTherapeutics, Inc.
    Inventors: Sean A. McCarthy, Michael Joseph Kuranda, Christine Ellen Bulawa, Steven Bossone
  • Patent number: 5888757
    Abstract: Disclosed are methods that can be used to (1) measure the level of polysaccharide in a sample; (2) measure the ability of a compound to degrade a polysaccharide; (3) measure the ability of a compound to modulate polysaccharide synthesis; and (4) identify or distinguish a polysaccharide, and hence organism, for diagnostic purposes in clinical medicine or research. The invention stems from Applicant's discovery that polysaccharides have multiple binding sites for polysaccharide binding moieties (PBM, e.g., wheat germ agglutinin (WGA)). In each method, one PBM links the polysaccharide to a substrate, and a tagged PBM is used to detect the polysaccharide. All of these methods can be carried out rapidly and quickly in the wells of a microtiter plate, thus permitting high through-put screening of samples or test compounds.
    Type: Grant
    Filed: May 3, 1996
    Date of Patent: March 30, 1999
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventor: Michael Joseph Kuranda